Lantheus Holdings

LNTH · NASDAQ

$100.39+$0.47 (+0.47%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $99.92

Latest news

Press releaseSep 29, 1:52 PM ETPRNewswire
Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?
Press releaseSep 28, 7:22 PM ETPRNewswire
ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH
Press releaseSep 22, 8:00 AM ETGlobe Newswire
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
Press releaseSep 11, 12:28 PM ETPRNewswire
Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?
Press releaseSep 10, 4:18 PM ETBusiness Wire
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
Press releaseAug 29, 7:41 AM ETBusiness Wire
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
NewsAug 14, 12:11 PM ETVandana Singh
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics
Press releaseAug 7, 2:16 PM ETPRNewswire
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
Press releaseAug 7, 11:02 AM ETBusiness Wire
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
NewsAug 6, 7:04 AM ET
Lantheus Holdings Q2 Adj. EPS $1.55 Beats $1.30 Estimate, Sales $388.200M Beat $362.416M Estimate
Press releaseAug 6, 7:00 AM ETGlobe Newswire
Lantheus Reports Second Quarter 2026 Financial Results
Press releaseAug 3, 3:23 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Press releaseAug 3, 1:41 PM ETPRNewswire
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
NewsAug 3, 12:53 PM ETVandana Singh
Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders
Press releaseAug 3, 11:13 AM ETPRNewswire
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders
Press releaseAug 3, 9:36 AM ETBusiness Wire
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Press releaseAug 3, 7:31 AM ETGlobe Newswire
Curium Announces Definitive Agreement to Merge with Lantheus
NewsJul 29, 3:30 PM ETTim Melvin
Under the Radar: 3 Boring Small Caps That Could Return 10x
Press releaseJul 23, 8:30 AM ETGlobe Newswire
Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
NewsJun 29, 9:51 AM ETVandana Singh
FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit
NewsJun 29, 2:34 AM ETAvi Kapoor
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday
Press releaseJun 26, 4:01 PM ETGlobe Newswire
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
Press releaseJun 2, 8:00 AM ETGlobe Newswire
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI's Image of the Year
NewsMay 22, 4:21 PM ET
'Lantheus Weighs Potential $7 Billion Sale Following Offer From Curium' - Bloomberg News
NewsMay 8, 10:59 AM ETAvi Kapoor
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results
NewsMay 7, 7:08 AM ET
Lantheus Holdings Q1 Adj. EPS $1.46 Beats $1.24 Estimate, Sales $377.330M Beat $353.942M Estimate
Press releaseMay 7, 7:00 AM ETGlobe Newswire
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
Press releaseApr 23, 8:00 AM ETGlobe Newswire
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
Press releaseMar 17, 4:01 PM ETGlobe Newswire
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
NewsMar 9, 2:43 AM ETAvi Kapoor
Korn Ferry, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Monday
Press releaseMar 6, 4:01 PM ETGlobe Newswire
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Press releaseMar 2, 12:19 PM ETBusiness Wire
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
Press releaseFeb 26, 7:00 AM ETGlobe Newswire
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Press releaseFeb 13, 10:20 PM ETPRNewswire
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
Press releaseFeb 12, 8:00 AM ETGlobe Newswire
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
Press releaseJan 31, 10:41 PM ETBusiness Wire
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
Press releaseDec 18, 4:54 PM ETGlobe Newswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseNov 13, 5:40 PM ETGlobe Newswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseNov 10, 11:43 AM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Lantheus, VFC, and Fluor Investors of the Upcoming Deadlines and Urges Investors to Contact the Firm
Press releaseNov 10, 11:20 AM ETBusiness Wire
LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit
Press releaseNov 10, 8:45 AM ETPRNewswire
Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH
Press releaseNov 8, 10:37 AM ETGlobe Newswire
LANTHEUS CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds Lantheus Stockholders to Contact the Firm Before November 10th Regarding Their Rights
Press releaseNov 6, 7:02 AM ETGlobe Newswire
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsDec 18, 1:30 PM ET
P/E Ratio Insights for Lantheus Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?

Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders

FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics

Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?

Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH

Lantheus Holdings Q2 Adj. EPS $1.55 Beats $1.30 Estimate, Sales $388.200M Beat $362.416M Estimate

Lantheus Reports Second Quarter 2026 Financial Results

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?

Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders

Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Curium Announces Definitive Agreement to Merge with Lantheus

Under the Radar: 3 Boring Small Caps That Could Return 10x

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit

Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI's Image of the Year

'Lantheus Weighs Potential $7 Billion Sale Following Offer From Curium' - Bloomberg News

These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results

Lantheus Holdings Q1 Adj. EPS $1.46 Beats $1.24 Estimate, Sales $377.330M Beat $353.942M Estimate

Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update

Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

Korn Ferry, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Monday

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Lantheus, VFC, and Fluor Investors of the Upcoming Deadlines and Urges Investors to Contact the Firm

LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit

Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH

LANTHEUS CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds Lantheus Stockholders to Contact the Firm Before November 10th Regarding Their Rights

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For November 6, 2025

P/E Ratio Insights for Lantheus Holdings